These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3655719)

  • 1. Surface localization of sialic acid on Actinomyces viscosus.
    Jones AH; Lee CC; Moncla BJ; Robinovitch MR; Birdsell DC
    J Gen Microbiol; 1986 Dec; 132(12):3381-91. PubMed ID: 3655719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14.
    Cisar JO; Vatter AE; McIntire FC
    Infect Immun; 1978 Jan; 19(1):312-9. PubMed ID: 624593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of surface composition of Actinomyces viscosus T14V and T14AV.
    Powell JT; Fischlschweiger W; Birdsell DC
    Infect Immun; 1978 Dec; 22(3):934-44. PubMed ID: 730385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical characterization of extracellular polysaccharides produced by Actinomyces viscosus T14V and T14Av.
    Imai S; Kuramitsu H
    Infect Immun; 1983 Mar; 39(3):1059-66. PubMed ID: 6840834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface fibrils (fimbriae) of Actinomyces viscosus T14V.
    Cisar JO; Vatter AE
    Infect Immun; 1979 May; 24(2):523-31. PubMed ID: 88416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence of Actinomyces viscosus T14V and T14AV to hydroxyapatite surfaces in vitro and human teeth in vivo.
    Wheeler TT; Clark WB; Birdsell DC
    Infect Immun; 1979 Sep; 25(3):1066-74. PubMed ID: 500185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
    Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
    Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.
    Mizuno J; Cisar JO; Vatter AE; Fennessey PV; McIntire FC
    Infect Immun; 1983 Jun; 40(3):1204-13. PubMed ID: 6303957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of physicochemical parameters on adsorption of Actinomyces viscosus to hydroxyapatite surfaces.
    Wheeler TT; Clark WB; Lane MD; Grow TE
    Infect Immun; 1983 Mar; 39(3):1095-101. PubMed ID: 6840836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialidase-enhanced lectin-like mechanism for Actinomyces viscosus and Actinomyces naeslundii hemagglutination.
    Ellen RP; Fillery ED; Chan KH; Grove DA
    Infect Immun; 1980 Feb; 27(2):335-43. PubMed ID: 6769798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Immunol; 1981 Oct; 127(4):1318-22. PubMed ID: 6115881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase-dependent hamagglutination of human erythrocytes by human strains of Actinomyces viscosus and Actinomyces naeslundii.
    Costello AH; Cisar JO; Kolenbrander PE; Gabriel O
    Infect Immun; 1979 Nov; 26(2):563-72. PubMed ID: 232691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model studies on dental plaque formation: deoxyhexoses in Actinomyces viscosus.
    Tylenda CA; Charon D; Lombardi FP; Gabriel O
    Infect Immun; 1979 Feb; 23(2):312-9. PubMed ID: 570555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological, chemical, and antigenic characterization of cell walls of the oral pathogenic strains Actinomyces viscosus T14V and T14AV.
    Brown DA; Fischlschweiger W; Birdsell DC
    Arch Oral Biol; 1980; 25(7):451-7. PubMed ID: 6935993
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphological, chemical and antigenic characterization of M-1 N-acetylmuramidase-digested cell walls of the oral pathogenic bacterium Actinomyces viscosus T14V and T14AV.
    Brown DA; Fischlschweiger W; Birdsell DC
    Arch Oral Biol; 1982; 27(3):183-91. PubMed ID: 6953934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of an Actinomyces viscosus T14V type 1 fimbrial subunit homolog among divergent groups of Actinomyces spp.
    Yeung MK
    Infect Immun; 1992 Mar; 60(3):1047-54. PubMed ID: 1347285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential distribution of sialic acid in exocrine pancreas and parotid gland.
    Mureşan Z; Mureşan V
    Acta Histochem; 1987; 81(1):109-15. PubMed ID: 3105211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of N-acetyl- and N-O-diacetyl-neuraminic acid derivatives in wild and mutant Crithidia fasciculata.
    Matta MA; Aleksitch V; Angluster J; Alviano CS; De Souza W; Andrade AF; Esteves MJ
    Parasitol Res; 1995; 81(5):426-33. PubMed ID: 7501643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.
    Cisar JO; David VA; Curl SH; Vatter AE
    Infect Immun; 1984 Nov; 46(2):453-8. PubMed ID: 6150007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.